BCM
RXST icon

Bridgeway Capital Management’s RxSight RXST Stock Holding History

Bridgeway Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Buy
+67,900
New +$410K 0.01% 961

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bridgeway Capital Management's RXST Position: Q2 2026 in Review

Bridgeway Capital Management opened a new position in RxSight (RXST) in Q2 2026: 67,900 shares worth $327K. The stake represents 0.01% of the portfolio and ranks #961 among its holdings.

151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Bridgeway Capital Management held 67,900 shares of RxSight worth $327K as of Q2 2026.
  • RxSight was a new Bridgeway Capital Management position in Q2 2026.
  • RxSight made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #961 holding.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.